|
|
Dialysis Company Pays $55M in Damages - ThirdAge |
|
Dialysis service provider DaVita Inc. will pay $55 million to settle a lawsuit related to overuse of an anemia medication.
The lawsuit was filed in 2002 and is based on a whistleblower's claim that DaVita overused Epogen, an anemia drug made by Amgen, over a 10-year period.
DaVita says its physicians did nothing wrong and stand by their anemia management practices, but the company says the agreement is in the best interest of its shareholders. In addition to $55 million, the company will pay attorney fees.
Epogen boosts oxygen-carrying red blood cells, reducing the need for painful blood transfusions. However a study in 2009 suggested Epogen and other drugs like it can double the risk of a stroke.
Denver-based DaVita runs about 1,800 outpatient dialysis centers nationwide.
|
|
|
Consumer Reports rates pediatric practices in Massachusetts |
|
Kaiser: Now Consumer Reports, a leading publisher of, among other things, buyers' guides for toasters and other appliances, has ventured into physician rating territory in Massachusetts. The ratings, published as an insert in the July issue for the magazine's Massachusetts subscribers and available online as well, put 487 primary-care and pediatric practices through their paces, assigning scores from 1 to 4 in each of five categories related to patient experience.
|
|
Avatar science fiction closer to reality than you would think. |
|
BBC: Robot avatars have got a step closer to being the real world doubles of those who are paralysed or have locked-in-syndrome.
|
|
CMS leaves reimbursement for home hemodialysis largely unchanged. |
|
Mass Device: The Centers for Medicare & Medicaid leave the home hemodialysis rule as it is, dashing some analysts' hopes of improved reimbursement status and a near-term upside for NxStage Medical.
|
|
Short course of immunotherapy reverses type 1 diabetes in mice. |
|
Newswise: Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections maintained disease remission indefinitely without harming the immune system.
|
|
|
|
|
<< Start < Prev 271 272 273 274 275 276 277 278 279 280 Next > End >>
|
|
Page 272 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
